Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing aripiprazole Lauroxil for schizophrenia.
Multiple locations, including CerritosThis study is completed in the United States. It is testing aripiprazole Lauroxil or Paliperidone Palmitate for schizophrenia.
Multiple locations, including Little RockThis study was terminated in the United States, in Belgium, in Brazil, .... It is testing Aticaprant 10 mg for depression.
Multiple locations, including HuntsvilleThis study is completed in the United States, in France, in Canada, .... It is testing Aticaprant 10 Milligrams (mg) for Depression.
Multiple locations, including BirminghamThis study is completed in the United States, in Australia, in Belgium, .... It is testing aticaprant for depression.
Multiple locations, including TucsonThis study was terminated in the United States, in Australia, in France, .... It is testing aticaprant for depression.
Multiple locations, including BirminghamThis study was terminated in the United States, in France, in Belgium, .... It is testing aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms for depression.
Multiple locations, including Little RockThis study is completed in the Netherlands. It is testing atomoxetine for ADHD.
In GroningenThis study is completed in the United States and in Canada. It is testing bitopertin for OCD.
Multiple locations, including Oceanside
This study is completed in the United States. It is testing brain Aging for PTSD.
Multiple locations, including Sun CityThis study is completed in the United States. It is testing BRII-296 for depression.
Multiple locations, including Sherman OaksThis study is completed in the United States, in India, in Malaysia, .... It is testing cariprazine for schizophrenia.
Multiple locations, including Costa MesaHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.